December 13, 2011
Christina Chan, professor of chemical engineering, was elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows for pioneering work in applying bioinformatics and systems biology techniques to understanding cellular processes dysregulated by fatty acids.
Chan--who also holds joint appointments in the Department of Computer Science and Engineering and in the Department of Biochemistry and Molecular Biology--serves as director of MSU's Cell and Molecular Biology Laboratory.
Her research group employs computational, molecular, and cellular engineering approaches to address biomedical problems. Specifically, her group is interested in an integrative approach to the study of medical and biological problems. Their research focuses specifically in the areas of bioinformatics and functional genomics and cellular and molecular engineering and their applications to understanding disease mechanisms. The group is also interested in identifying molecular signatures and potential drug targets for treating diseases such as obesity, Alzheimer's disease, and cancer. They are also developing drug delivery and tissue engineering platforms to modulate the pathways to treat these diseases.
AIMBE is a nonprofit organization representing 50,000 individuals and the top 2 percent of medical and biological engineers. Founded in 1991 to provide leadership and advocacy for the benefit of society, it is composed of engineering and medical school chairs, research directors, innovators, and successful entrepreneurs.
Chan is among 107 inductees who will be honored at a formal ceremony on February 20, 2012, during AIMBE's 21st Annual Event at the Grand Hyatt in Washington, D.C.